Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01437319 · ClinicalTrials.gov registry record · Phase 1
Mucin Balls and Corneal Inflammation Events
A Phase 1 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 1
- Development phase
- 289
- Enrollment target
NCT01437319 is a Phase 1 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 289 participants.
The verdict
NCT01437319, a Phase 1 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 289 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the formation of mucin balls is a marker for protection from inflammatory events to the cornea and if mucin balls play a role in protection during extended contact lens wear.
Interventions
- DEVICE comfilcon A
- DEVICE balafilcon A
- DEVICE lotrafilcon A
- OTHER etafilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01437319
The ClinicalTrials.gov registry entry for NCT01437319 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which comfilcon A is the first listed.
NCT01437319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01437319 about?
NCT01437319 is a clinical study titled "Mucin Balls and Corneal Inflammation Events". The purpose of this study is to determine if the formation of mucin balls is a marker for protection from inflammatory events to the cornea and if mucin balls play a role in protection during extended contact lens wear.
What is the current status of trial NCT01437319?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 289 participants. The study started on 2011-09. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01437319?
The interventions under investigation include: comfilcon A (DEVICE), balafilcon A (DEVICE), lotrafilcon A (DEVICE), etafilcon A (OTHER).
Who is sponsoring clinical trial NCT01437319?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.